Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody−Associated Disease

Objectives To characterize the serum cytokine profile in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) at onset and during follow-up and assess their utility for predicting relapses and disability. Methods This retrospective multicentric cohort study included patients aged...

Descripción completa

Detalles Bibliográficos
Autores: Villacieros Álvarez, Javier, Espejo Ruiz, Carmen, Arrambide, Georgina, Dinoto, Alessandro, Mulero Carrillo, Patricia, Rubio Flores, Laura, Nieto González, Pablo, Alcalá, Carmen, Meca Lallana, José E., Millan Pascual, Jorge, Martínez García, Pedro, Bernard Valnet, Raphael, González Suárez, Inés, Orviz García, Aída, Téllez Pérez, Raquel, Navarro Cantó, Laura, Presas Rodríguez, Silvia, Martínez Yélamos, Sergio, Cuello, Juan Pablo, Alonso Torres, Ana María, Piñar Morales, Raquel, Álvarez Bravo, Gary, Benyahya, Lakhdar, Trouillet Assant, Sophie, Dyon Tafan, Virginie, Froment Tilikete, Caroline, Ruet, Aurélie, Bourre, Bertrand, Deschamps, Romain, Papeix, Caroline, Maillart, Elisabeth, Kerschen, Philippe, Ayrignac, Xavier, Rovira, Àlex, Auger Acosta, Cristina, Audoin, Bertrand, Montalbán Gairín, Xavier, Tintoré Subirana, Mar, Mariotto, Sara, Cobo Calvo, Álvaro, Marignier, Romain
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2025
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/221373
Acceso en línea:https://hdl.handle.net/2445/221373
Access Level:acceso abierto
Palabra clave:Neuroimmunologia
Autoanticossos
Neuroimmunology
Autoantibodies
id ES_80751f8bf490d70bc1c56b4bcd1de9c3
oai_identifier_str oai:recercat.cat:2445/221373
network_acronym_str ES
network_name_str España
repository_id_str
spelling Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody−Associated DiseaseVillacieros Álvarez, JavierEspejo Ruiz, CarmenArrambide, GeorginaDinoto, AlessandroMulero Carrillo, PatriciaRubio Flores, LauraNieto González, PabloAlcalá, CarmenMeca Lallana, José E.Millan Pascual, JorgeMartínez García, PedroBernard Valnet, RaphaelGonzález Suárez, InésOrviz García, AídaTéllez Pérez, RaquelNavarro Cantó, LauraPresas Rodríguez, SilviaMartínez Yélamos, SergioCuello, Juan PabloAlonso Torres, Ana MaríaPiñar Morales, RaquelÁlvarez Bravo, GaryBenyahya, LakhdarTrouillet Assant, SophieDyon Tafan, VirginieFroment Tilikete, CarolineRuet, AurélieBourre, BertrandDeschamps, RomainPapeix, CarolineMaillart, ElisabethKerschen, PhilippeAyrignac, XavierRovira, ÀlexAuger Acosta, CristinaAudoin, BertrandMontalbán Gairín, XavierTintoré Subirana, MarMariotto, SaraCobo Calvo, ÁlvaroMarignier, RomainNeuroimmunologiaAutoanticossosNeuroimmunologyAutoantibodiesObjectives To characterize the serum cytokine profile in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) at onset and during follow-up and assess their utility for predicting relapses and disability. Methods This retrospective multicentric cohort study included patients aged 16 years and older meeting MOGAD 2023 criteria, with serum samples collected at baseline (<= 3 months from disease onset) and follow-up (>= 6 months from the baseline), and age-matched and time to sampling-matched patients with multiple sclerosis (MS). Eleven cytokines were assessed using the ELLA system. Data comparisons and statistical analyses between cytokine levels and clinical outcomes were performed. Results Eighty-eight patients with MOGAD and 32 patients with MS were included. Patients with MOGAD showed higher IL6 (p = 0.036), IL8 (p = 0.012), and IL18 (p = 0.026) baseline levels compared with those with MS, in non-optic neuritis (ON) presentations. BAFF values increased over time, especially in patients with MOGAD treated with anti-CD20 (p = 0.002). Baseline BAFF, CXCL10, IL10, and IL8 levels correlated with disease severity at MOGAD onset (all p < 0.05). Finally, higher baseline BAFF levels predicted lower risk of relapses (hazard ratio 0.41 [0.19; 0.89], p = 0.024). Discussion This study suggests a proinflammatory Th17-dominant profile in non-ON MOGAD patients, with a novel finding of a potential protective role of BAFF on relapses. These results shed new light on the pathogenesis of MOGAD, potentially guiding therapeutic decisions.Ovid Technologies (Wolters Kluwer Health)2025202520252025info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion7 p.application/pdfhttps://hdl.handle.net/2445/221373Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésReproducció del document publicat a: https://doi.org/10.1212/NXI.0000000000200362Neurology Neuroimmunology & Neuroinflammation, 2025, vol. 12, num. 2https://doi.org/10.1212/NXI.0000000000200362cc-by (c) Villacieros Álvarez et al., 2025http://creativecommons.org/licenses/by/3.0/es/info:eu-repo/semantics/openAccessoai:recercat.cat:2445/2213732026-05-29T05:05:01Z
dc.title.none.fl_str_mv Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody−Associated Disease
title Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody−Associated Disease
spellingShingle Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody−Associated Disease
Villacieros Álvarez, Javier
Neuroimmunologia
Autoanticossos
Neuroimmunology
Autoantibodies
title_short Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody−Associated Disease
title_full Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody−Associated Disease
title_fullStr Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody−Associated Disease
title_full_unstemmed Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody−Associated Disease
title_sort Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody−Associated Disease
dc.creator.none.fl_str_mv Villacieros Álvarez, Javier
Espejo Ruiz, Carmen
Arrambide, Georgina
Dinoto, Alessandro
Mulero Carrillo, Patricia
Rubio Flores, Laura
Nieto González, Pablo
Alcalá, Carmen
Meca Lallana, José E.
Millan Pascual, Jorge
Martínez García, Pedro
Bernard Valnet, Raphael
González Suárez, Inés
Orviz García, Aída
Téllez Pérez, Raquel
Navarro Cantó, Laura
Presas Rodríguez, Silvia
Martínez Yélamos, Sergio
Cuello, Juan Pablo
Alonso Torres, Ana María
Piñar Morales, Raquel
Álvarez Bravo, Gary
Benyahya, Lakhdar
Trouillet Assant, Sophie
Dyon Tafan, Virginie
Froment Tilikete, Caroline
Ruet, Aurélie
Bourre, Bertrand
Deschamps, Romain
Papeix, Caroline
Maillart, Elisabeth
Kerschen, Philippe
Ayrignac, Xavier
Rovira, Àlex
Auger Acosta, Cristina
Audoin, Bertrand
Montalbán Gairín, Xavier
Tintoré Subirana, Mar
Mariotto, Sara
Cobo Calvo, Álvaro
Marignier, Romain
author Villacieros Álvarez, Javier
author_facet Villacieros Álvarez, Javier
Espejo Ruiz, Carmen
Arrambide, Georgina
Dinoto, Alessandro
Mulero Carrillo, Patricia
Rubio Flores, Laura
Nieto González, Pablo
Alcalá, Carmen
Meca Lallana, José E.
Millan Pascual, Jorge
Martínez García, Pedro
Bernard Valnet, Raphael
González Suárez, Inés
Orviz García, Aída
Téllez Pérez, Raquel
Navarro Cantó, Laura
Presas Rodríguez, Silvia
Martínez Yélamos, Sergio
Cuello, Juan Pablo
Alonso Torres, Ana María
Piñar Morales, Raquel
Álvarez Bravo, Gary
Benyahya, Lakhdar
Trouillet Assant, Sophie
Dyon Tafan, Virginie
Froment Tilikete, Caroline
Ruet, Aurélie
Bourre, Bertrand
Deschamps, Romain
Papeix, Caroline
Maillart, Elisabeth
Kerschen, Philippe
Ayrignac, Xavier
Rovira, Àlex
Auger Acosta, Cristina
Audoin, Bertrand
Montalbán Gairín, Xavier
Tintoré Subirana, Mar
Mariotto, Sara
Cobo Calvo, Álvaro
Marignier, Romain
author_role author
author2 Espejo Ruiz, Carmen
Arrambide, Georgina
Dinoto, Alessandro
Mulero Carrillo, Patricia
Rubio Flores, Laura
Nieto González, Pablo
Alcalá, Carmen
Meca Lallana, José E.
Millan Pascual, Jorge
Martínez García, Pedro
Bernard Valnet, Raphael
González Suárez, Inés
Orviz García, Aída
Téllez Pérez, Raquel
Navarro Cantó, Laura
Presas Rodríguez, Silvia
Martínez Yélamos, Sergio
Cuello, Juan Pablo
Alonso Torres, Ana María
Piñar Morales, Raquel
Álvarez Bravo, Gary
Benyahya, Lakhdar
Trouillet Assant, Sophie
Dyon Tafan, Virginie
Froment Tilikete, Caroline
Ruet, Aurélie
Bourre, Bertrand
Deschamps, Romain
Papeix, Caroline
Maillart, Elisabeth
Kerschen, Philippe
Ayrignac, Xavier
Rovira, Àlex
Auger Acosta, Cristina
Audoin, Bertrand
Montalbán Gairín, Xavier
Tintoré Subirana, Mar
Mariotto, Sara
Cobo Calvo, Álvaro
Marignier, Romain
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Neuroimmunologia
Autoanticossos
Neuroimmunology
Autoantibodies
topic Neuroimmunologia
Autoanticossos
Neuroimmunology
Autoantibodies
description Objectives To characterize the serum cytokine profile in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) at onset and during follow-up and assess their utility for predicting relapses and disability. Methods This retrospective multicentric cohort study included patients aged 16 years and older meeting MOGAD 2023 criteria, with serum samples collected at baseline (<= 3 months from disease onset) and follow-up (>= 6 months from the baseline), and age-matched and time to sampling-matched patients with multiple sclerosis (MS). Eleven cytokines were assessed using the ELLA system. Data comparisons and statistical analyses between cytokine levels and clinical outcomes were performed. Results Eighty-eight patients with MOGAD and 32 patients with MS were included. Patients with MOGAD showed higher IL6 (p = 0.036), IL8 (p = 0.012), and IL18 (p = 0.026) baseline levels compared with those with MS, in non-optic neuritis (ON) presentations. BAFF values increased over time, especially in patients with MOGAD treated with anti-CD20 (p = 0.002). Baseline BAFF, CXCL10, IL10, and IL8 levels correlated with disease severity at MOGAD onset (all p < 0.05). Finally, higher baseline BAFF levels predicted lower risk of relapses (hazard ratio 0.41 [0.19; 0.89], p = 0.024). Discussion This study suggests a proinflammatory Th17-dominant profile in non-ON MOGAD patients, with a novel finding of a potential protective role of BAFF on relapses. These results shed new light on the pathogenesis of MOGAD, potentially guiding therapeutic decisions.
publishDate 2025
dc.date.none.fl_str_mv 2025
2025
2025
2025
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/221373
url https://hdl.handle.net/2445/221373
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Reproducció del document publicat a: https://doi.org/10.1212/NXI.0000000000200362
Neurology Neuroimmunology & Neuroinflammation, 2025, vol. 12, num. 2
https://doi.org/10.1212/NXI.0000000000200362
dc.rights.none.fl_str_mv cc-by (c) Villacieros Álvarez et al., 2025
http://creativecommons.org/licenses/by/3.0/es/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv cc-by (c) Villacieros Álvarez et al., 2025
http://creativecommons.org/licenses/by/3.0/es/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 7 p.
application/pdf
dc.publisher.none.fl_str_mv Ovid Technologies (Wolters Kluwer Health)
publisher.none.fl_str_mv Ovid Technologies (Wolters Kluwer Health)
dc.source.none.fl_str_mv Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869411900167553024
score 15,811543